
### [NCIT:C5799](http://purl.obolibrary.org/obo/NCIT_C5799)
**Label:** Benign Childhood Supratentorial Neoplasm

**Subclasses:** [NCIT:C6219](http://purl.obolibrary.org/obo/NCIT_C6219) (Benign Childhood Cerebral Neoplasm), [NCIT:C9476](http://purl.obolibrary.org/obo/NCIT_C9476) (Desmoplastic Infantile Astrocytoma), [NCIT:C4738](http://purl.obolibrary.org/obo/NCIT_C4738) (Desmoplastic Infantile Ganglioglioma), 

**Class expressions from DL-Learner:**

- [NCIT:C53666](http://purl.obolibrary.org/obo/NCIT_C53666) (Malignant Cell with Large Nucleus and Abundant Eosinophilic Cytoplasm) 53.33%
- [NCIT:C37147](http://purl.obolibrary.org/obo/NCIT_C37147) (Neoplastic Oligodendrocyte-Like Cell) 53.33%
- [NCIT:C37141](http://purl.obolibrary.org/obo/NCIT_C37141) (Neoplastic Oligodendrocyte) 53.33%
- Thing 53.10%
- [NCIT:C37143](http://purl.obolibrary.org/obo/NCIT_C37143) (Neoplastic Ependymal Cell) 38.69%
- [NCIT:C37143](http://purl.obolibrary.org/obo/NCIT_C37143) (Neoplastic Ependymal Cell) and (not ([NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor))) 38.69%
- [NCIT:C37143](http://purl.obolibrary.org/obo/NCIT_C37143) (Neoplastic Ependymal Cell) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 38.69%
- [NCIT:C37143](http://purl.obolibrary.org/obo/NCIT_C37143) (Neoplastic Ependymal Cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 38.69%
- [NCIT:C37143](http://purl.obolibrary.org/obo/NCIT_C37143) (Neoplastic Ependymal Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 38.69%
- [NCIT:C37143](http://purl.obolibrary.org/obo/NCIT_C37143) (Neoplastic Ependymal Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 38.69%
- [NCIT:C37143](http://purl.obolibrary.org/obo/NCIT_C37143) (Neoplastic Ependymal Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 38.69%
- [NCIT:C37143](http://purl.obolibrary.org/obo/NCIT_C37143) (Neoplastic Ependymal Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 38.69%
- [NCIT:C37143](http://purl.obolibrary.org/obo/NCIT_C37143) (Neoplastic Ependymal Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 38.69%
- [NCIT:C37143](http://purl.obolibrary.org/obo/NCIT_C37143) (Neoplastic Ependymal Cell) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 38.69%
- [NCIT:C37143](http://purl.obolibrary.org/obo/NCIT_C37143) (Neoplastic Ependymal Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 38.69%


